SCHEMBL526192

SCHEMBL526192

Cc1cccc(-c2cn(C(=O)N(C)C3CCCCC3)cn2)c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.67
CES2 O00748 1/20 0.67
POLB P06746 4/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
PKM P14618 1/20 0.43
USP19 O94966 1/20 0.42
TRPV1 Q8NER1 2/20 0.41
TRPA1 O75762 1/20 0.41
MGLL Q99685 1/20 0.41
S1PR1 P21453 1/20 0.40
ABCC1 P33527 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMO O15229 1/20 0.38
GRM5 P41594 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14950284 0.99 FAAH (0.66) FAAHCES2POLBKMT2ANPC1
SCHEMBL424383 0.89 FAAH (0.74) FAAHCES2POLBKMT2ANPC1
SCHEMBL14950286 0.89 FAAH (0.54) FAAHCES2KMOGRM5
SCHEMBL425372 0.89 FAAH (0.67) FAAHCES2POLBKMT2ANPC1
SCHEMBL424585 0.89 FAAH (0.67) FAAHCES2POLBKMT2ANPC1
SCHEMBL14950289 0.88 FAAH (0.66) FAAHCES2POLBNPC1RAB9A
SCHEMBL524996 0.88 FAAH (0.66) FAAHCES2POLBKMT2ANPC1
SCHEMBL427164 0.88 FAAH (0.66) FAAHCES2POLBKMT2ANPC1
SCHEMBL427830 0.87 FAAH (0.66) FAAHCES2POLBKMT2ANPC1
SCHEMBL14950186 0.87 FAAH (0.64) FAAHCES2POLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606035-B1 PROCES FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA S A (PT) 2017-09-06 EP disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 US disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 US disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 US disclosed
EP-2606035-A1 PROCES FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - Portela & CA., S.A. (PT) 2013-06-26 EP disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 US disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 US disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 US disclosed
WO-2012015324-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2012-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS UTS2R, ARG1, PRMT1 FAAH 2166/4885CES2 463/4885POLB 1328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.